Terms and conditions for access to and use of report2017.novozymes.com
report2017.novozymes.com is exclusively owned, controlled and maintained by Novozymes A/S. The following terms and conditions apply to any and all uses of report2017.novozymes.com or its content. By accessing and using report2017.novozymes.com you unconditionally accept these terms and conditions without qualification, limitation or other restriction.
Laws and regulations
Accessing and using report2017.novozymes.com are activities in which you engage at your own initiative and choice. You are solely responsible for compliance with any and all applicable laws, statutes, regulations or other restrictions governing such access and use of report2017.novozymes.com. Its text, content, information, educational and promotional material, releases to the public, descriptions, graphics and functions (the "content") are made available at the sole discretion of Novozymes.
Disclaimer for ADRs
ADRs are certificates issued by a US depositary institution or bank representing deposited shares of a non-US corporation. ADRs are quoted and traded in the US securities market. US depositary institutions or banks are permitted to establish ADR programs without the participation or even the consent of the non-US corporation. The exemption is based on the reasonable, good faith belief that the non-US corporation publishes certain information in English on its website. Novozymes does not support or encourage the creation of unsponsored ADR programs in respect of its securities and disclaims any liability in connection with any unsponsored ADR program. Novozymes does not represent to any depositary institution and does not warrant that all information in English relevant for ADRs is stated in The Novozymes Report.
Changes and content
The content and URL on this website that are referred to in The Novozymes Report may be changed, suspended or removed without prior notice in compliance with applicable law. Regardless of the reason, Novozymes assumes no responsibility whatsoever for any loss or damage resulting from changes, suspension or deletion of information contained in The Novozymes Report or information on Novozymes’ website referred to therein, or from the unauthorized alteration of said information by a third party, or for damage resulting from the downloading of the data. report2017.novozymes.com contains forward-looking statements, including Novozymes’ financial outlook for 2018, which, by their very nature, are associated with risks and uncertainties that may cause actual results to differ materially from expectations. Uncertainties may include unexpected developments in the international currency exchange and securities markets, market-driven price decreases for Novozymes’ products and the introduction of competing products in Novozymes’ core areas.
Copyright
All content is copyrighted or controlled by Novozymes. You are welcome to access and browse all areas of report2017.novozymes.com. Some areas may require user validation. Download of any aspect of the content for noncommercial use within your organization is permitted, provided that any downloaded material retains any and all indications of copyright, trademark or other proprietary status.
Trademarks
Product names and signs used to distinguish goods and services on this site, whether or not appearing in large print, bold or with the trademark symbol, are trademarks and service marks of the Novozymes Group, related companies or our licensors or joint venture partners. While Novozymes registers trademarks in many jurisdictions, some marks might not be registered in the country from which you are accessing the site.
Terms and conditions for linking to report2017.novozymes.com
You are welcome to provide a link to Novozymes’ website from your own website. Organizations or private individuals attempting such action in ways considered harmful or in bad faith will be asked to desist. In providing this link opportunity, we request the following:
